(Q40680870)

22 September 2017

Optimal composite scores for longitudinal clinical trials under the linear mixed effects model (English)

1 reference

22 September 2017

3

Steven D Edland

1 reference

22 September 2017

M Colin Ard

1

1 reference

22 September 2017

Nandini Raghavan

series ordinal

2

1 reference

22 September 2017

30 July 2015

1 reference

Pharmaceutical Statistics

22 September 2017

1 reference

22 September 2017

14

1 reference

22 September 2017

5

1 reference

22 September 2017

418-426

1 reference

describes a project that uses

22 September 2017

ggplot2

object named as

R package ggplot2

1 reference

CZ Software Mentions: A large dataset of software mentions in the biomedical literature

cites work

The preclinical Alzheimer cognitive composite: measuring amyloid-related decline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5132034

An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5132034

The A4 study: stopping AD before symptoms begin?

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5132034

Combining Multiple Markers to Improve the Longitudinal Rate of Progression-Application to Clinical Trials on the Early Stage of Alzheimer's Disease

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5132034

The ADAS-Cog revisited: novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5132034

Improved statistical power of Alzheimer clinical trials by item-response theory: proof of concept by application to the activities of daily living scale

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5132034

Power calculations for clinical trials in Alzheimer's disease

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5132034

Vitamin E and donepezil for the treatment of mild cognitive impairment

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5132034

Regulatory innovation and drug development for early-stage Alzheimer's disease

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5132034

Accounting for dropout bias using mixed-effects models.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5132034

19 August 2018

Identifiers

DOI

10.1002/PST.1701

1 reference

22 September 2017

1 reference

22 September 2017

PubMed publication ID

26223663

1 reference